Heart failure and tachycardia-induced cardiomyopathy

Current Heart Failure Reports

Volumn 10, Issue 4, 2013, Pages 296-306

  Ellis, Ethan R ^a   Josephson, Mark E ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Atrial fibrillation; Cardiomyopathy; Congestive heart failure; Premature ventricular contractions; Premature ventricular depolarizations; Supraventricular tachycardia; Tachycardia induced cardiomyopathy; Tachycardia mediated cardiomyopathy; Ventricular tachycardia

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENALIN; ALDOSTERONE; ANGIOTENSIN II; ANTIARRHYTHMIC AGENT; ATRIAL NATRIURETIC FACTOR; CREATINE; CREATINE PHOSPHATE; GLYCOGEN; NORADRENALIN;

APOPTOSIS; ARTERIAL PRESSURE; ARTICLE; ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA; BASEMENT MEMBRANE; BODY SURFACE; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; EXCITATION CONTRACTION COUPLING; EXTRACELLULAR MATRIX; FOLLOW UP; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM PACEMAKER; HEART ATRIUM PACING; HEART CATHETERIZATION; HEART DEPOLARIZATION; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART OUTPUT; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LUNG ARTERY PRESSURE; MONOMORPHIC VENTRICULAR TACHYCARDIA; NONHUMAN; OXIDATIVE STRESS; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PAROXYSMAL TACHYCARDIA; PATHOGENESIS; PATHOPHYSIOLOGY; RESTING HEART RATE; SINUS RHYTHM; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; TACHYCARDIA INDUCED CARDIOMYOPATHY; UPREGULATION;

ANIMALS; DEATH, SUDDEN, CARDIAC; DISEASE MODELS, ANIMAL; HEART FAILURE; HUMANS; PROGNOSIS; RECURRENCE; TACHYCARDIA; VENTRICULAR DYSFUNCTION;

EID: 84888040487     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-013-0150-z     Document Type: Article

References (100)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.
2. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 2002;39:60-9.
3. Owan TE, Redfield MM. Epidemiology of diastolic heart failure. Progr Cardiovasc Dis. 2005;47:320-32.
4. Gossage AM, Braxton Hicks J. On auricular fibrillation. QJM 1913:435-40.
5. Coleman 3rd HN, Taylor RR, Pool PE, et al. Congestive heart failure following chronic tachycardia. Am Heart J. 1971;81:790-8.
6. Armstrong PW, Stopps TP, Ford SE, de Bold AJ. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation. 1986;74:1075-84.
7. Wilson JR, Douglas P, Hickey WF, et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation. 1987;75:857-67.
8. Scott BD, Sharma MK, Levett JM, et al. Cardiac geometry and mass changes associated with pacing-induced cardiomyopathy in the dog. Am Heart J. 1993;125:1047-53.
9. Spinale FG, Hendrick DA, Crawford FA, Smith AC, Hamada Y, Carabello BA. Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am J Physiol. 1990;259:H218-29.
10. Thackray SD, Witte KK, Nikitin NP, Clark AL, Kaye GC, Cleland JG. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J. 2003;24:1143-52.
11. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288:3115-23.
12. Gardiwal A, Yu H, Oswald H, et al. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator. Europace. 2008;10:358-63.
13. Delgado V, Tops LF, Trines SA, et al. Acute effects of right ventricular apical pacing on left ventricular synchrony and mechanics. Circ Arrhythmia Electrophysiol. 2009;2:135-45.
14. Lee SJ, McCulloch C, Mangat I, Foster E, De Marco T, Saxon LA. Isolated bundle branch block and left ventricular dysfunction. J Card Fail. 2003;9:87-92.
15. Blanc JJ, Fatemi M, Bertault V, Baraket F, Etienne Y. Evaluation of left bundle branch block as a reversible cause of non-ischaemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular dyssynchrony-induced cardiomyopathy. Europace. 2005;7:604-10.
16. ten Cate FE U, Kruessell MA, Wagner K, et al. Dilated cardiomyopathy in children with ventricular preexcitation: the location of the accessory pathway is predictive of this association. J Electrocardiol. 2010;43:146-54.
17. Cadrin-Tourigny J, Fournier A, Andelfinger G, Khairy P. Severe left ventricular dysfunction in infants with ventricular preexcitation. Heart Rhythm. 2008;5:1320-2.
18. Howard RJ, Moe GW, Armstrong PW. Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failure. Cardiovasc Res. 1991;25:468-74.
19. Shannon RP, Komamura K, Stambler BS, Bigaud M, Manders WT, Vatner SF. Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy. Am J Physiol. 1991;260:H1903-11.
20. Ohno M, Cheng CP, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation. 1994;89:2241-50.
21. Howard RJ, Stopps TP, Moe GW, Gotlieb A, Armstrong PW. Recovery from heart failure: structural and functional analysis in a canine model. Can J Physiol Pharmacol. 1988;66:1505-12.
22. Morgan DE, Tomlinson CW, Qayumi AK, Toleikis PM, McConville B, Jamieson WR. Evaluation of ventricular contractility indexes in the dog with left ventricular dysfunction induced by rapid atrial pacing. J Am Coll Cardiol. 1989;14:489-95. discussion 96-8.
23. O'Brien PJ, Ianuzzo CD, Moe GW, Stopps TP, Armstrong PW. Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies. Can J Physiol Pharmacol. 1990;68:34-9.
24. Moe GW, Stopps TP, Howard RJ, Armstrong PW. Early recovery from heart failure: insights into the pathogenesis of experimental chronic pacing-induced heart failure. J Lab Clin Med. 1988;112:426-32.
25. Tanaka R, Spinale FG, Crawford FA, Zile MR. Effect of chronic supraventricular tachycardia on left ventricular function and structure in newborn pigs. J Am Coll Cardiol. 1992;20:1650-60.
26. Moe GW, Angus C, Howard RJ, Parker TG, Armstrong PW. Evaluation of indices of left ventricular contractility and relaxation in evolving canine experimental heart failure. Cardiovasc Res. 1992;26:362-6.
27. Tibayan FA, Lai DT, Timek TA, et al. Alterations in left ventricular torsion in tachycardia-induced dilated cardiomyopathy. J Thorac Cardiovasc Surg. 2002;124:43-9.
28. Damiano Jr RJ, Tripp Jr HF, Asano T, Small KW, Jones RH, Lowe JE. Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia. J Thorac Cardiovasc Surg. 1987;94:135-43.
29. Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Zile MR. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol. 1991;261:H308-18.
30. Riegger AJ, Liebau G. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci (Lond). 1982;62:465-9.
31. Moe GW, Stopps TP, Angus C, Forster C, De Bold AJ, Armstrong PW. Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol. 1989;13:173-9.
32. Spinale FG, Clayton C, Tanaka R, et al. Myocardial Na+, K(+)-ATPase in tachycardia induced cardiomyopathy. J Mol Cell Cardiol. 1992;24:277-94.
33. Qin F, Shite J, Mao W, Liang CS. Selegiline attenuates cardiac oxidative stress and apoptosis in heart failure: association with improvement of cardiac function. Eur J Pharmacol. 2003;461:149-58.
34. Shite J, Qin F, Mao W, Kawai H, Stevens SY, Liang C. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy. J Am Coll Cardiol. 2001;38:1734-40.
35. Spinale FG, Grine RC, Tempel GE, Crawford FA, Zile MR. Alterations in the myocardial capillary vasculature accompany tachycardia-induced cardiomyopathy. Basic Res Cardiol. 1992;87:65-79.
36. Shannon RP, Komamura K, Shen YT, Bishop SP, Vatner SF. Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure. Am J Physiol. 1993;265:H801-9.
37. Calderone A, Bouvier M, Li K, Juneau C, de Champlain J, Rouleau JL. Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res. 1991;69:332-43.
38. Marzo KP, Frey MJ, Wilson JR, et al. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res. 1991;69:1546-56.
39. Yonemochi H, Yasunaga S, Teshima Y, et al. Rapid electrical stimulation of contraction reduces the density of beta-adrenergic receptors and responsiveness of cultured neonatal rat cardiomyocytes. Possible involvement of microtubule disassembly secondary to mechanical stress. Circulation. 2000;101:2625-30.
40. Omichi C, Tanaka T, Kakizawa Y, et al. Improvement of cardiac function and neurological remodeling in a patient with tachycardia-induced cardiomyopathy after catheter ablation. J Cardiol. 2009;54:134-8.
41. Perreault CL, Shannon RP, Komamura K, Vatner SF, Morgan JP. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Investig. 1992;89:932-8.
42. Yamamoto K, Burnett Jr JC, Meyer LM, Sinclair L, Stevens TL, Redfield MM. Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model. Am J Physiol. 1996;271:R1529-34.
43. Spinale FG, Holzgrefe HH, Mukherjee R, et al. LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol. 1995;268:H836-47.
44. Tomita M, Spinale FG, Crawford FA, Zile MR. Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function. Circulation. 1991;83:635-44.
45. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997;29:709-15.
46. Krapp M, Gembruch U, Baumann P. Venous blood flow pattern suggesting tachycardia-induced 'cardiomyopathy' in the fetus. Ultrasound Obstet Gynecol. 1997;10:32-40.
47. Dhala A, Thomas JP. Images in cardiovascular medicine. Reversible tachycardia-induced cardiomyopathy. Circulation. 1997;95:2327-8.
48. Sanchez C, Benito F, Moreno F. Reversibility of tachycardia-induced cardiomyopathy after radiofrequency ablation of incessant supraventricular tachycardia in infants. Br Heart J. 1995;74:332-3.
49. De Giovanni JV, Dindar A, Griffith MJ, et al. Recovery pattern of left ventricular dysfunction following radiofrequency ablation of incessant supraventricular tachycardia in infants and children. Heart. 1998;79:588-92.
50. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359-64.
51. Van Gelder IC, Crijns HJ, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 1993;72:560-6.
52. Twidale N, Sutton K, Bartlett L, et al. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol. 1993;16:1275-84.
53. Heinz G, Siostrzonek P, Kreiner G, Gossinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol. 1992;69:489-92.
54. Manolis AG, Katsivas AG, Lazaris EE, Vassilopoulos CV, Louvros NE. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias. J Intervent Card Electrophysiol. 1998;2:71-6.
55. Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, Ellenbogen KA. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc. 2000;75:790-5.
56. Brignole M, Gianfranchi L, Menozzi C, et al. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol. 1994;74:242-6.
57. Natale A, Zimerman L, Tomassoni G, et al. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol. 1996;78:1431-3.
58. • Gentlesk PJ, Sauer WH, Gerstenfeld EP, et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18:9-14. This is a single center study reporting outcomes for patients with atrial fibrillation and depressed left ventricular function following catheter ablation.
59. • Pizzale S, Lemery R, Green MS, Gollob MH, Tang AS, Birnie DH. Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter. Can J Cardiol. 2009;25:469-72. This is a recent single center study reporting the incidence and outcomes of patients with tachycardia-induced cardiomyopathy secondary to atrial flutter.
60. Scheinman MM, Basu D, Hollenberg M. Electrophysiologic studies in patients with persistent atrial tachycardia. Circulation. 1974;50:266-73.
61. Bertil Olsson S, Blomstrom P, Sabel KG, William-Olsson G. Incessant ectopic atrial tachycardia: successful surgical treatment with regression of dilated cardiomyopathy picture. Am J Cardiol. 1984;53:1465-6.
62. Gillette PC, Smith RT, Garson Jr A, et al. Chronic supraventricular tachycardia. A curable cause of congestive cardiomyopathy. JAMA. 1985;253:391-2.
63. Gillette PC, Wampler DG, Garson Jr A, Zinner A, Ott D, Cooley D. Treatment of atrial automatic tachycardia by ablation procedures. J Am Coll Cardiol. 1985;6:405-9.
64. Cruz FE, Cheriex EC, Smeets JL, et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol. 1990;16:739-44.
65. Chiladakis JA, Vassilikos VP, Maounis TN, Cokkinos DV, Manolis AS. Successful radiofrequency catheter ablation of automatic atrial tachycardia with regression of the cardiomyopathy picture. Pacing Clin Electrophysiol. 1997;20:953-9.
66. • Medi C, Kalman JM, Haqqani H, et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol. 2009;53:1791-7. This is a recent single center study reporting the incidence and long-term outcomes of patients with tachycardia-induced cardiomyopathy secondary to incessant atrial tachycardia.
67. Packer DL, Bardy GH, Worley SJ, et al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol. 1986;57:563-70.
68. Fishberger SB, Colan SD, Saul JP, Mayer Jr JE, Walsh EP. Myocardial mechanics before and after ablation of chronic tachycardia. Pacing Clin Electrophysiol. 1996;19:42-9.
69. Aguinaga L, Primo J, Anguera I, et al. Long-term follow-up in patients with the permanent form of junctional reciprocating tachycardia treated with radiofrequency ablation. Pacing Clin Electrophysiol. 1998;21:2073-8.
70. Corey WA, Markel ML, Hoit BD, Walsh RA. Regression of a dilated cardiomyopathy after radiofrequency ablation of incessant supraventricular tachycardia. Am Heart J. 1993;126:1469-73.
71. Leman RB, Gillette PC, Zinner AJ. Resolution of congestive cardiomyopathy caused by supraventricular tachycardia using amiodarone. Am Heart J. 1986;112:622-4.
72. Wu D, Denes P, Dhingra R, Pietras RJ, Rosen KM. New manifestations of dual A-V nodal pathways. Eur J Cardiol. 1975;2:459-66.
73. • Wang NC. Dual atrioventricular nodal nonreentrant tachycardia: a systematic review. Pacing Clin Electrophysiol. 2011;34:1671-81. This is a recent systematic review of all reported cases of dual atrioventricular nodal nonreentrant tachycardia reporting the prevalence of tachycardia-induced cardiomyopathy as well as its response to treatment.
74. Anselme F, Boyle N, Josephson M. Incessant fascicular tachycardia: a cause of arrhythmia induced cardiomyopathy. Pacing Clin Electrophysiol. 1998;21:760-3.
75. Vijgen J, Hill P, Biblo LA, Carlson MD. Tachycardia-induced cardiomyopathy secondary to right ventricular outflow tract ventricular tachycardia: improvement of left ventricular systolic function after radiofrequency catheter ablation of the arrhythmia. J Cardiovasc Electrophysiol. 1997;8:445-50.
76. Singh B, Kaul U, Talwar KK, Wasir HS. Reversibility of tachycardia induced cardiomyopathy following the cure of idiopathic left ventricular tachycardia using radiofrequency energy. Pacing Clin Electrophysiol. 1996;19:1391-2.
77. • Hasdemir C, Ulucan C, Yavuzgil O, et al. Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors. J Cardiovasc Electrophysiol. 2011;22:663-8. This is a recent single center study reporting the prevalence of tachycardia-induced cardiomyopathy in patients presenting with premature ventricular contractions and/or ventricular tachycardia, as well as predictors of the development of tachycardia-induced cardiomyopathy.
78. Grimm W, Menz V, Hoffmann J, Maisch B. Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia. Pacing Clin Electrophysiol. 2001;24:166-71.
79. • Baman TS, Lange DC, Ilg KJ, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm. 2010;7:865-9. This is a recent single center study of patients with frequent idiopathic premature ventricular contractions reporting the relationship to premature ventricular contraction burden and the development of tachycardia-induced cardiomyopathy.
80. Satish OS, Yeh KH, Wen MS, Wang CC. Premature ventricular contraction-induced concealed mechanical bradycardia and dilated cardiomyopathy. J Cardiovasc Electrophysiol. 2005;16:88-91.
81. Bogun F, Crawford T, Reich S, et al. Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm. 2007;4:863-7.
82. • Mountantonakis SE, Frankel DS, Gerstenfeld EP, et al. Reversal of outflow tract ventricular premature depolarization-induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome. Heart Rhythm. 2011;8:1608-14. This is a single center study reporting the safety, efficacy, and long-term effect of catheter ablation of premature ventricular contractions on left ventricular dysfunction, as well as the impact of residual premature ventricular contractions on recovery of left ventricular function.
83. • Deyell MW, Park KM, Han Y, et al. Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations. Heart Rhythm. 2012;9:1465-72. This is a recent single center study reporting predictors of recovery of left ventricular function following ablation of frequent premature ventricular contractions.
84. • Yokokawa M, Kim HM, Good E, et al. Impact of QRS duration of frequent premature ventricular complexes on the development of cardiomyopathy. Heart Rhythm. 2012;9:1460-4. This is a recent single center study evaluating the impact of QRS duration of frequent premature contractions on the development of cardiomyopathy.
85. • Yokokawa M, Good E, Crawford T, et al. Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes. Heart Rhythm. 2013;10:172-5. This is a recent single center study reporting the time course and predictors of recovery of left ventricular dysfunction after ablation of premature ventricular contractions.
86. Hasdemir C, Musayev O, Kehribar DY, Kartal Y, Can LH. Chronic Cough and Tachycardia-Induced Cardiomyopathy in a Patient with Idiopathic Frequent, Monomorphic Premature Ventricular Contractions. Pacing Clin Electrophysiol. 2011;36:e156-8.
87. • Del Carpio Munoz F, Syed FF, Noheria A, et al. Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs. J Cardiovasc Electrophysiol. 2011;22:791-8. This is a single center study reporting predictors of cardiomyopathy development in patients with frequent premature ventricular contractions.
88. Niwano S, Wakisaka Y, Niwano H, et al. Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function. Heart. 2009;95:1230-7.
89. Kanei Y, Friedman M, Ogawa N, Hanon S, Lam P, Schweitzer P. Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction. Ann Noninvasive Electrocardiol. 2008;13:81-5.
90. • Hasdemir C, Kartal Y, Simsek E, Yavuzgil O, Aydin M, Can LH. Time Course of Recovery of Left Ventricular Systolic Dysfunction in Patients with Premature Ventricular Contraction-Induced Cardiomyopathy. Pacing Clin Electrophysiol. 2013;36:612-7. This is a recent single center study reporting time course and degree of recovery of left ventricular dysfunction following treatment of arrhythmias based on echocardiographic characteristics.
91. Jeong YH, Choi KJ, Song JM, et al. Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy. Clin Cardiol. 2008;31:172-8.
92. Rabbani LE, Wang PJ, Couper GL, Friedman PL. Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia. Am Heart J. 1991;121:816-9.
93. Lee SH, Chen SA, Tai CT, et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol. 1998;31:637-44.
94. Dandamudi G, Rampurwala AY, Mahenthiran J, Miller JM, Das MK. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. Heart Rhythm. 2008;5:1111-4.
95. Nerheim P, Birger-Botkin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation. 2004;110:247-52.
96. Watanabe H, Okamura K, Chinushi M, et al. Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy. Int Heart J. 2008;49:39-47.
97. Kieny JR, Sacrez A, Facello A, et al. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J. 1992;13:1290-5.
98. Ilkhanoff L, Gerstenfeld EP, Zado ES, Marchlinski FE. Changes in ventricular dimensions and function during recovery of atrial tachycardia-induced cardiomyopathy treated with catheter ablation. J Cardiovasc Electrophysiol. 2007;18:1104-6.
99. Lacroix D, Gluais P, Marquie C, D'Hoinne C, Adamantidis M, Bastide M. Repolarization abnormalities and their arrhythmogenic consequences in porcine tachycardia-induced cardiomyopathy. Cardiovasc Res. 2002;54:42-50.
100. Pak PH, Nuss HB, Tunin RS, et al. Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy. J Am Coll Cardiol. 1997;30:576-84.